An updated approach to healthcare-associated meningitis
Küçük Resim Yok
Tarih
2014
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Taylor & Francis Ltd
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Among hospital-associated infections, healthcare-associated central nervous system infections are quite important because of high morbidity and mortality rates. The causative agents of healthcare-associated meningitis differ according to the status of immune systems and underlying diseases. The most frequent agents are Gram-negative bacilli (Pseudomonas spp., Acinetobacter spp., Escherichia coli and Klebsiella pneumoniae) and Gram-positive cocci (Staphylococcus aureus and coagulase-negative staphylococci). There are currently several problems in the treatment strategies of healthcare-associated meningitis due to a globally increasing resistance problem. Strategies targeting multidrug-resistant pathogens are especially limited. This review focuses on healthcare-associated meningitis and the current treatment strategies with a particular focus on methicillin-resistant Staphylococcus aureus (MRSA) meningitis.
Açıklama
Anahtar Kelimeler
Acinetobacter baumannii, amikacin, carbapenem-resistant, cefepime, ceftazidime, colistin, daptomycin, Escherichia coli, hospital acquired meningitis, Klebsiella pneumoniae, linezolid, MDR, meropenem, methicillin-resistant Staphylococcus aureus, nosocomial meningitis, Pseudomonas aeruginosa, teicoplanin, therapy, tigecycline, treatment of hospital acquired meningitides, vancomycin, XDR
Kaynak
Expert Review of Anti-Infective Therapy
WoS Q Değeri
Q1
Scopus Q Değeri
Q1
Cilt
12
Sayı
3
